Literature DB >> 10747214

Idiopathic prolonged QT interval and QT dispersion: the effects of propofol during implantation of cardioverter-defibrillator.

D Michaloudis1, O Fraidakis, E Kanoupakis, A Flossos, E Manios.   

Abstract

Local anaesthesia combined with conscious sedation is becoming a popular technique for implantation of cardioverter-defibrillator devices. Propofol was given to provide loss of consciousness during defibrillation shock administration, for induced ventricular fibrillation testing. Propofol was found to decrease QT interval and QT dispersion in two patients with idiopathic prolonged QT interval and QT dispersion. The findings of the procedure are reported.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10747214     DOI: 10.1046/j.1365-2346.1999.00599.x

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  4 in total

Review 1.  Propofol and arrhythmias: two sides of the coin.

Authors:  Qiang Liu; Ai-ling Kong; Rong Chen; Cheng Qian; Shao-wen Liu; Bao-gui Sun; Le-xin Wang; Long-sheng Song; Jiang Hong
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

2.  Dental treatment of a patient with long QT syndrome under moderate sedation with target-controlled infusion of propofol.

Authors:  Kyung Jin Kim; Hong-Keun Hyun; Young-Jae Kim; Jung-Wook Kim; Teo Jeon Shin
Journal:  J Dent Anesth Pain Med       Date:  2015-09-30

Review 3.  Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.

Authors:  Fabrizio De Ponti; Elisabetta Poluzzi; Andrea Cavalli; Maurizio Recanatini; Nicola Montanaro
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Differential effects of propofol and sevoflurane on QT interval during anesthetic induction.

Authors:  Makito Oji; Yoshiaki Terao; Tomomi Toyoda; Tomoyuki Kuriyama; Kosuke Miura; Makoto Fukusaki; Koji Sumikawa
Journal:  J Clin Monit Comput       Date:  2012-12-15       Impact factor: 2.502

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.